Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-κB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia

Acta Haematol. 2019;141(3):135-137. doi: 10.1159/000495741. Epub 2019 Feb 15.

Affiliations

¹ Department of Hematology, Graduate School of Medicine, Gunma University, Maebashi, Japan.
² Department of Health Science, Graduate School of Health Sciences, Gunma University, Maebashi, Japan.
³ Department of Medicine, Tokushima University, Tokushima, Japan.
⁴ Department of Hematology, Graduate School of Medicine, Gunma University, Maebashi, Japan, handahiroshi@gunma-u.ac.jp.

PMID: 30783036
DOI: 10.1159/000495741

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Gene Expression Regulation, Leukemic*
Humans
Hypercalcemia / etiology
Hypercalcemia / metabolism*
Hypercalcemia / pathology
Male
Neoplasm Proteins / biosynthesis*
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / pathology
RANK Ligand / biosynthesis*

Substances

Neoplasm Proteins
RANK Ligand
TNFSF11 protein, human